http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101472574-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-64 |
| filingDate | 2013-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2014-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101472574-B1 |
| titleOfInvention | A pharmaceutical comprising apamin for treating or preventing acute pancreatitis |
| abstract | The present invention relates to a composition for inhibiting the onset of acute pancreatitis in pancreatic tissues and lung tissues by containing afamin as an active ingredient. The composition according to the present invention reduces inflammation and edema in pancreatic tissue, efficacy to inhibit MPO infiltration in pancreatic tissue, ratio of pancreas weight / body weight (PW / BW), amount of amylase and lipase in serum in pancreatic tissue , The efficacy of proinflammatory cytokine and proinflammatory cytokine mRNA expression in pancreatic tissue, and the activity of MAPKs pathway in pancreatic tissue. In addition, the composition according to the present invention has an effect of inhibiting inflammation and edema in lung tissue and MPO infiltration in lung tissue. |
| priorityDate | 2013-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 372.